Bristol-Myers, 3M and Deckers rise premarket; Dexcom falls

Investing.com -- U.S. stock futures rose Friday, rebounding after some hefty losses ahead of the release of key inflation data.

Here are some of the biggest premarket U.S. stock movers today:

  • 3M Company (NYSE:MMM) stock rose 6.5% after the industrial conglomerate raised the low end of its full-year adjusted profit forecast expecting to benefit from restructuring measures and increasing demand for electronics.

  • Bristol-Myers Squibb (NYSE:BMY) stock rose 4.6% after the drugmaker posted better-than-expected second-quarter results, driven by growth from new products like anemia treatment Reblozyl and heart drug Camzyos as well as from its top-seller, blood thinner Eliquis.

  • Apple (NASDAQ:AAPL) stock rose 1.1%, boosted by the positive overall tone despite its smartphone shipments in China falling by 6.7% in the second quarter of 2024, according to data from market research firm Canalys.

  • Novo Nordisk (CSE:NOVOb) (NYSE:NVO) stock rose 0.6% after the drugmaker’s blockbuster Wegovy weight loss drug received backing from the European Union’s medical regulator backing to reduce heart risks.

  • Deckers Outdoor (NYSE:DECK) stock soared 12% after the athletics shoes and apparel company raised its annual profit forecast following a first-quarter results beat.

  • Dexcom (NASDAQ:DXCM) stock slumped 37% after the medical device maker cut its annual revenue forecast, saying it had fewer new customers than expected.

  • Baker Hughes (NASDAQ:BKR) stock rose 1.9% after the oilfield services firm beat estimates for second-quarter profit, helped by a strong international performance.

  • Charter Communications (NASDAQ:CHTR) stock soared 9.5% after the cable company beat second-quarter earnings expectations.

  • Walmart (NYSE:WMT) stock rose 0.3% after Reuters reported that the retail giant plans to potentially spend $200 million on self-driving forklifts as part of broader efforts to automate more warehouse operations.

This content was originally published on Investing.com